52 related articles for article (PubMed ID: 17822619)
1. [Signal transduction pathways and esophageal carcinoma].
Li SS
Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):366-9. PubMed ID: 17822619
[No Abstract] [Full Text] [Related]
2. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma.
Fukuchi M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Sohda M; Manda R; Tsukada K; Kato H; Kuwano H
Int J Cancer; 2004 Mar; 108(6):818-24. PubMed ID: 14712482
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma.
Ritprajak P; Azuma M
Oral Oncol; 2015 Mar; 51(3):221-8. PubMed ID: 25500094
[TBL] [Abstract][Full Text] [Related]
4. Wnt-11 signaling leads to down-regulation of the Wnt/beta-catenin, JNK/AP-1 and NF-kappaB pathways and promotes viability in the CHO-K1 cells.
Railo A; Nagy II; Kilpeläinen P; Vainio S
Exp Cell Res; 2008 Aug; 314(13):2389-99. PubMed ID: 18572162
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical profiling of Wnt, NF-kappaB, Stat3 and Notch signaling in human epidermal tumors.
Liu ZL; Li Y; Kong QY; Zhan C; Wang Q; Chen XY; Sun Y; Wen S; Tu CX; Liu J; Li H
J Dermatol Sci; 2008 Nov; 52(2):133-6. PubMed ID: 18703315
[No Abstract] [Full Text] [Related]
6. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.
Fukuchi M; Nakajima M; Miyazaki T; Masuda N; Osawa H; Manda R; Tsukada K; Kato H; Kuwano H
J Surg Oncol; 2006 Jul; 94(1):51-6. PubMed ID: 16788944
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.
Osawa H; Nakajima M; Kato H; Fukuchi M; Kuwano H
Anticancer Res; 2004; 24(6):3703-9. PubMed ID: 15736400
[TBL] [Abstract][Full Text] [Related]
8. [Effect of β-catenin gene silencing by shRNA on biologic characteristics of human esophageal carcinoma cells].
Wang JS; Ji AF; Wen JF; Ren HZ
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):835-41. PubMed ID: 21215100
[TBL] [Abstract][Full Text] [Related]
9. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
10. Progression of esophageal carcinoma by loss of EGF-STAT1 pathway.
Watanabe G; Kaganoi J; Imamura M; Shimada Y; Itami A; Uchida S; Sato F; Kitagawa M
Cancer J; 2001; 7(2):132-9. PubMed ID: 11324766
[TBL] [Abstract][Full Text] [Related]
11. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
Lin ML; Lu YC; Chen HY; Lee CC; Chung JG; Chen SS
Mol Carcinog; 2014 May; 53(5):360-79. PubMed ID: 23192861
[TBL] [Abstract][Full Text] [Related]
12. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral polymorphonuclear granulocyte is associated with poor prognosis in squamous esophageal cancer by promoting epithelial-mesenchymal transition.
Hu P; Wang G; Shen M; Zhang P; Zhang J; Du J; Liu Q
Future Oncol; 2015; 11(5):771-83. PubMed ID: 25757681
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E(2) promotes cell proliferation via protein kinase C/extracellular signal regulated kinase pathway-dependent induction of c-Myc expression in human esophageal squamous cell carcinoma cells.
Yu L; Wu WK; Li ZJ; Li HT; Wu YC; Cho CH
Int J Cancer; 2009 Dec; 125(11):2540-6. PubMed ID: 19623651
[TBL] [Abstract][Full Text] [Related]
15. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.
Yang F; Zeng Q; Yu G; Li S; Wang CY
Cell Signal; 2006 May; 18(5):679-87. PubMed ID: 16084063
[TBL] [Abstract][Full Text] [Related]
16. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
Edmiston JS; Yeudall WA; Chung TD; Lebman DA
Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
[TBL] [Abstract][Full Text] [Related]
17. Centrality and the shortest path approach in the human interactome.
Rubanova N; Morozova N
J Bioinform Comput Biol; 2019 Aug; 17(4):1950027. PubMed ID: 31617463
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cytokine signaling pathways by PIAS proteins.
Shuai K
Cell Res; 2006 Feb; 16(2):196-202. PubMed ID: 16474434
[TBL] [Abstract][Full Text] [Related]
19. Expression of CARD6, an NF-kappaB activator, in gastric, colorectal and oesophageal cancers.
Kim SS; Ahn CH; Kang MR; Kim YR; Kim HS; Yoo NJ; Lee SH
Pathology; 2010 Jan; 42(1):50-3. PubMed ID: 20025480
[TBL] [Abstract][Full Text] [Related]
20. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.
Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T
Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
